CITF Research Results

CITF Research Results2022-01-27T09:23:33-05:00

Findings show clear advantages of Moderna vaccine for long-term care residents

A CITF-funded study in preprint, not yet peer-reviewed, led by Drs. Dawn Bowdish and Andrew Costa from McMaster University, showed that among residents of long-term care facilities, there was a lower risk of an Omicron infection when the person had:

  • Received three doses of Moderna or a combination including Moderna (vs. three doses of Pfizer);
  • Any fourth mRNA vaccine dose; and
  • Hybrid immunity induced by 3 vaccine doses and a SARS-CoV-2 infection in the 3 months prior to the beginning of the Omicron wave.
July 18, 2022|Long-term care & seniors|
Go to Top